189 related articles for article (PubMed ID: 26782397)
21. A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population.
Chu H; Gu D; Xu M; Xu Z; Gong Y; Gong W; Tang Y; Zhou J; Tong N; Zhang Z; Chen J; Wang M
Mutagenesis; 2013 Jul; 28(4):441-6. PubMed ID: 23680703
[TBL] [Abstract][Full Text] [Related]
22. Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma.
Ji WP; He NB
Int J Clin Exp Pathol; 2015; 8(1):894-9. PubMed ID: 25755792
[TBL] [Abstract][Full Text] [Related]
23. Association of ERCC gene polymorphism with osteosarcoma risk.
Wang G; Li J; Xu X; Gupta RK; Gao X
Afr Health Sci; 2020 Dec; 20(4):1840-1848. PubMed ID: 34394247
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients.
Pérez-Ramírez C; Cañadas-Garre M; Alnatsha A; Villar E; Valdivia-Bautista J; Faus-Dáder MJ; Calleja-Hernández MÁ
Pharmacogenomics J; 2019 Apr; 19(2):164-177. PubMed ID: 29662106
[TBL] [Abstract][Full Text] [Related]
25. Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer.
He MG; Zheng K; Tan D; Wang ZX
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051038
[TBL] [Abstract][Full Text] [Related]
26. A Comprehensive Analysis of Influence ERCC Polymorphisms Confer on the Development of Brain Tumors.
Geng P; Ou J; Li J; Liao Y; Wang N; Xie G; Sa R; Liu C; Xiang L; Liang H
Mol Neurobiol; 2016 May; 53(4):2705-14. PubMed ID: 26264164
[TBL] [Abstract][Full Text] [Related]
27. Predictive Value of Two Polymorphisms of ERCC2, rs13181 and rs1799793, in Clinical Outcomes of Chemotherapy in Gastric Cancer Patients: A Meta-Analysis.
Li M; Zhao Y; Zhao E; Wang K; Lu W; Yuan L
Dis Markers; 2018; 2018():3947626. PubMed ID: 30581498
[TBL] [Abstract][Full Text] [Related]
28. The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients.
Obiedat H; Alrabadi N; Sultan E; Al Shatti M; Zihlif M
BMC Med Genet; 2018 Jul; 19(1):112. PubMed ID: 29980176
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in ERCC1 and ERCC2/XPD genes and carcinogen DNA adducts in human lung.
Lee MS; Liu CY; Su L; Christiani DC
Lung Cancer; 2015 Jul; 89(1):8-12. PubMed ID: 26001533
[TBL] [Abstract][Full Text] [Related]
30. Study on the ERCC1 gene polymorphism response to chemotherapy and prognosis of gastric cancer.
Liu L; Li CH; Jin TF; Xu DY
Genet Mol Res; 2014 Oct; 13(4):8722-8. PubMed ID: 25366763
[TBL] [Abstract][Full Text] [Related]
31. Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy.
Lu ZM; Luo TH; Nie MM; Fang GE; Ma LY; Xue XC; Wei G; Ke CW; Bi JW
Tumour Biol; 2014 Apr; 35(4):2941-8. PubMed ID: 24318989
[TBL] [Abstract][Full Text] [Related]
32. ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy.
Rumiato E; Cavallin F; Boldrin E; Cagol M; Alfieri R; Basso D; Castoro C; Ancona E; Amadori A; Ruol A; Saggioro D
Pharmacogenet Genomics; 2013 Nov; 23(11):597-604. PubMed ID: 23962907
[TBL] [Abstract][Full Text] [Related]
33. Association between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population.
Zhao R; Ying MF
Genet Mol Res; 2016 Mar; 15(1):15017263. PubMed ID: 26985954
[TBL] [Abstract][Full Text] [Related]
34. Association of genetic polymorphisms in ERCC1 and ERCC2/XPD with risk of chronic benzene poisoning in a Chinese occupational population.
Xiao S; Gao L; Liu Y; Yu T; Jin C; Pan L; Zhu G; Lu X
Mutat Res; 2013 Feb; 751(1):52-8. PubMed ID: 23147699
[TBL] [Abstract][Full Text] [Related]
35. Study of association between pre-senile cataracts and rs11615 of ERCC1, rs13181 of ERCC2, and rs25487 of XRCC1 polymorphisms in a Spanish population.
López-Valverde G; Garcia-Martin E; Fernández-Mateos J; Cruz-González F; Larrosa-Povés JM; Polo-Llorens V; Pablo-Júlvez LE; González-Sarmiento R
Ophthalmic Genet; 2017; 38(4):314-319. PubMed ID: 27668351
[TBL] [Abstract][Full Text] [Related]
36. Involvement of ERCC1 (rs3212986) and ERCC2 (rs1799793, rs13181) polymorphisms of DNA repair genes in breast cancer occurrence in Burkina Faso.
Adico MDW; Zouré AA; Sombié HK; Kiendrebeogo TI; Dabré S; Amegnona LJ; Bakyono BS; Traoré L; Ouedraogo TC; Ouedraogo RA; Zohoncon TM; Yonli AT; Bayala B; Bambara HA; Djigma FW; Simpore J
Mol Genet Genomic Med; 2023 Apr; 11(4):e2134. PubMed ID: 36594475
[TBL] [Abstract][Full Text] [Related]
37. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
[TBL] [Abstract][Full Text] [Related]
38. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk.
Zhou CX; Zhao JH
Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436
[TBL] [Abstract][Full Text] [Related]
39. ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis.
Yin M; Yan J; Martinez-Balibrea E; Graziano F; Lenz HJ; Kim HJ; Robert J; Im SA; Wang WS; Etienne-Grimaldi MC; Wei Q
Clin Cancer Res; 2011 Mar; 17(6):1632-40. PubMed ID: 21278243
[TBL] [Abstract][Full Text] [Related]
40. Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer.
Chen ZH; Wang L; Luo LP
Genet Mol Res; 2014 Sep; 13(3):7484-91. PubMed ID: 25222248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
